Pereira, N., Lino, C., Fonseca, N., Martins, B., Pereira, J., Souza-Fagundes, E., Rosa, C., Assis, D., Barbosa, R., Johann, S. Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro. European Journal of Medicinal Chemistry, 2015. 102, 233-242.
2. Hoang, L., Philips, P., Galanis, E. Cryptococcus gattii: a Review of the Epidemiology, Clinical Presentation, Diagnosis, and Management of This Endemic Yeast in the Pacific Northwest. Clinical Microbiology Newsletter, 2011. 33(24), 187-195.
3. Byrnes, E. J., Bildfell, R. J., Dearing, P. L., Valentine, B. A., & Heitman, J. (2009). Cryptococcus gattii with bimorphic colony types in a dog in Western Oregon: additional evidence for expansion of the Vancouver Island outbreak. Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc, 21(1), 133–136.
4. Kitaura, T., Takahashi, M., Umeyama, T., Takeshita, N., Katanami, Y., Takaya, S., Yamamoto, K., Kutsuna, S., Hayakawa, K., Kato, Y., Yamauchi, T., Narita, Y., Miyazaki, Y., Ohmagari, N. Cryptococcus gattii genotype VGIIa infection imported from Vancouver Island to Japan. Journal of Infection and Chemotherapy. In Press, 1-3.
5. Nodarse Hernández Rafael, Bravo Pérez Rigoberto. Clinical and microbiological aspects in an immunocompetent patient with cryptococcosis of the central nervous system. Rev Cub Med Mil [Internet]. 1999 Abr [citado 2018 Jun 19] ; 28( 1 ): 67-72. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65571999000100010&lng=es.
6. Sivaranjini, A., Uma, S., Anupma, K., Shankar, V. Cryptococcus gattii meningitis in a young adult in South India: A case report. International Journal of Case Reports and Images, 2015. 6(11), 702-706.
7. Rosen, L., Freeman, A., Yang, L., Jutivorakool, K., Olivier, K., Angkasekwinai, N. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. Journal of Immunology, 2013. 190, 3959–3966.
8. Strasinger, S., Di Lorenzo, M. Análisis de orina y de los líquidos corporales. 5e Madrid, Editorial Médica Panamericana; 2008.
9. Teelo Mercedes, Gutiérrez Ericson, Béjar Vilma, Galarza Carlos, Ramos Willy, Ortega-Loayza Alex G. Criptococosis. Rev. Méd. Risaralda 2013; 19 (2):147-153
10. Bonifaz, A. Micología Médica Básica. 5e New York, NY: McGraw-Hill; 2015.
11. Mellado Emilia, Cuenca-Estrella Manuel, Rodríguez-Tudela Juan Luis. Importancia clínica de los mecanismos de resistencia de los hongos filamentosos a los antifúngicos. Enferm infecc Microbiol Clín [Internet]. 2002 Dic [citado 2018 Jun 19]. Disponible en: http://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28 articulo-importancia-clinica-los-mecanismos-resistencia
